Northstar Group’s Amgen AMGN Stock Holding History

Northstar Group’s Portfolio AMGN Stock Details AMGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$517K	Sell	1,468 -15	-1%	-$5.35K	0.07%	102
2025 Q4	$485K	Hold	1,483	–	–	0.07%	104
2025 Q3	$419K	Sell	1,483 -18	-1%	-$5.22K	0.06%	104
2025 Q2	$419K	Hold	1,501	–	–	0.06%	102
2025 Q1	$468K	Buy	1,501 +49	+3%	+$14.5K	0.08%	94
2024 Q4	$378K	Buy	1,452 +17	+1%	+$5.04K	0.06%	105
2024 Q3	$462K	Hold	1,435	–	–	0.08%	93
2024 Q2	$448K	Sell	1,435 -78	-5%	-$22.9K	0.08%	89
2024 Q1	$430K	Sell	1,513 -80	-5%	-$23.4K	0.08%	95
2023 Q4	$459K	Sell	1,593 -19	-1%	-$5.18K	0.1%	87
2023 Q3	$433K	Hold	1,612	–	–	0.1%	92
2023 Q2	$358K	Sell	1,612 -41	-2%	-$9.51K	0.08%	106
2023 Q1	$400K	Hold	1,653	–	–	0.1%	98
2022 Q4	$434K	Sell	1,653 -90	-5%	-$24.1K	0.12%	94
2022 Q3	$393K	Hold	1,743	–	–	0.12%	94
2022 Q2	$424K	Sell	1,743 -90	-5%	-$22.1K	0.12%	95
2022 Q1	$443K	Hold	1,833	–	–	0.11%	100
2021 Q4	$412K	Hold	1,833	–	–	0.1%	105
2021 Q3	$390K	Hold	1,833	–	–	0.1%	111
2021 Q2	$447K	Hold	1,833	–	–	0.12%	106
2021 Q1	$456K	Buy	1,833 +62	+4%	+$14.8K	0.13%	104
2020 Q4	$407K	Sell	1,771 -70	-4%	-$16.1K	0.12%	104
2020 Q3	$468K	Hold	1,841	–	–	0.16%	89
2020 Q2	$434K	Sell	1,841 -55	-3%	-$12.5K	0.18%	85
2020 Q1	$384K	Sell	1,896 -190	-9%	-$41.5K	0.18%	85
2019 Q4	$503K	Sell	2,086 -219	-10%	-$48.3K	0.19%	83
2019 Q3	$446K	Sell	2,305 -110	-5%	-$21.1K	0.19%	88
2019 Q2	$445K	Hold	2,415	–	–	0.19%	90
2019 Q1	$459K	Sell	2,415 -50	-2%	-$9.55K	0.21%	86
2018 Q4	$480K	Hold	2,465	–	–	0.24%	81
2018 Q3	$511K	Sell	2,465 -93	-4%	-$18.3K	0.23%	83
2018 Q2	$472K	Sell	2,558 -50	-2%	-$8.84K	0.24%	82
2018 Q1	$445K	Sell	2,608 -157	-6%	-$28.8K	0.23%	82
2017 Q4	$481K	Buy	2,765 +50	+2%	+$8.85K	0.25%	81
2017 Q3	$506K	Buy	2,715 +435	+19%	+$77.1K	0.29%	75
2017 Q2	$393K	Hold	2,280	–	–	0.24%	82
2017 Q1	$374K	Sell	2,280 -250	-10%	-$41.5K	0.25%	81
2016 Q4	$370K	Hold	2,530	–	–	0.26%	75
2016 Q3	$422K	Hold	2,530	–	–	0.3%	71
2016 Q2	$385K	Hold	2,530	–	–	0.29%	71
2016 Q1	$379K	Sell	2,530 -210	-8%	-$31.2K	0.29%	71
2015 Q4	$444K	Hold	2,740	–	–	0.35%	70
2015 Q3	$390K	Buy	2,740 +20	+0.7%	+$3.15K	0.32%	71
2015 Q2	$418K	Buy	2,720 +380	+16%	+$60.9K	0.32%	71
2015 Q1	$374K	Sell	2,340 -100	-4%	-$15.7K	0.29%	77
2014 Q4	$389K	Buy	+2,440	New	+$380K	0.3%	76

Other funds holding AMGN

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Northstar Group's AMGN Position: Q1 2026 in Review

Northstar Group reduced its Amgen (AMGN) stake by 1% in Q1 2026, selling an estimated $5.35K and leaving 1,468 shares worth $517K. The position accounts for 0.07% of the portfolio, ranked #102.

Northstar Group first reported a position in AMGN in Q4 2014 and has held it in 46 quarters since. 3,131 funds tracked by Wall St. Rank hold AMGN as of Q1 2026.

Northstar Group held 1,468 shares of Amgen worth $517K as of Q1 2026.
Northstar Group sold 15 Amgen shares in Q1 2026, an estimated $5.35K.
Amgen made up 0.07% of Northstar Group's portfolio in Q1 2026, its #102 holding.
Northstar Group first reported a position in Amgen in Q4 2014 and has held it in 46 quarters since.
3,131 funds tracked by Wall St. Rank held Amgen as of Q1 2026.

Based on Northstar Group's 13F filing for Q1 2026, filed 28 Apr 2026.